As a result of the sudden Zika virus outbreak, both big pharma companies and non-profits alike are diving head first into vaccine research in hopes of halting this life-threatening virus. First to the table was Sanofi Pasteur, announcing that they “would lead the way against Zika”. Following their successful launch of the dengue fever vaccine, Sanofi is confident they can tackle Zika as the two viruses are similar in nature. Apart from Sanofi’s progress, the WHO has announced that fifteen other groups, both government agencies and big pharma are also working on a vaccine formulation.
To read more about progress on the Zika vaccine, click here.
Editorial Associate
Lily Stauffer serves as an Editorial Associate for DTC Perspectives. She is currently a senior at Saint Joseph's University, studying Pharmaceutical Marketing and Spanish.
No comments yet.